Andrzejewski Kryspin, Kaczyńska Katarzyna, Zaremba Małgorzata
Laboratory of Respiration Physiology, Mossakowski Medical Research Centre Polish Academy of Sciences, Pawińskiego 5, 02-106, Warsaw, Poland.
Department of Experimental and Clinical Pharmacology, Centre for Preclinical Research (CePT), Medical University of Warsaw, Warsaw, Poland.
J Biomed Sci. 2017 Mar 27;24(1):24. doi: 10.1186/s12929-017-0331-2.
Malfunctioning of the serotonergic system in Parkinson's disease may contribute to non-motor symptoms such as respiratory complications. Thus the aim of our study was to investigate the role of serotonin 5-HT receptors in the modulation of normoxic breathing and the hypoxic ventilatory response (HVR) in rat model of Parkinson's disease.
Wistar rats were lesioned unilaterally with double 6-hydroxydopamine (6-OHDA) injection to the right medial forebrain bundle (MFB). Before lesion and two weeks later animals were put in whole body plethysmography chamber and exposed to hypoxia (8% O). Before hypoxic tests animals received intraperitoneal injections of DOI and ketanserin. Efficacy of lesion was confirmed by cylinder test, assessing limb use asymmetry.
Degeneration of the nigrostriatal pathway augmented response of tidal volume and minute ventilation to hypoxia. DOI administration in control and lesion state caused a significant rise in normoxic respiratory rate and minute ventilation. Yet, ventilatory response of these parameters to hypoxia was attenuated. Post-DOI magnitude of HVR in lesioned state was decreased in compare to pre-lesion control. Subsequent ketanserin injection reverted DOI-induced respiratory effects. We demonstrated that 6-OHDA treatment decreased the content of serotonin in the injured striatum and on both sides of the brainstem, leaving the concentration of noradrenaline on unchanged level.
These observations showed that damage of the nigrostriatal system initiates changes in the serotonergic system, confirmed by reduced concentration of serotonin in the striatum and brainstem, which affects the magnitude of respiratory response to hypoxia after activation of 5-HT receptors.
帕金森病中血清素能系统功能失调可能导致呼吸并发症等非运动症状。因此,我们研究的目的是调查血清素5-羟色胺受体在帕金森病大鼠模型中对常氧呼吸调节和低氧通气反应(HVR)的作用。
对Wistar大鼠右侧内侧前脑束(MFB)单侧注射双剂量6-羟基多巴胺(6-OHDA)造成损伤。在损伤前及损伤两周后,将动物放入全身体积描记室并暴露于低氧环境(8%氧气)。在低氧测试前,动物接受腹腔注射DOI和酮色林。通过圆筒试验评估肢体使用不对称性,以确认损伤的有效性。
黑质纹状体通路的退化增强了潮气量和分钟通气量对低氧的反应。在对照和损伤状态下给予DOI均导致常氧呼吸频率和分钟通气量显著增加。然而,这些参数对低氧的通气反应减弱。与损伤前对照相比,损伤状态下DOI给药后HVR的幅度降低。随后注射酮色林可逆转DOI引起的呼吸效应。我们证明,6-OHDA处理降低了损伤纹状体和脑干两侧的血清素含量,而去甲肾上腺素浓度保持不变。
这些观察结果表明,黑质纹状体系统损伤引发了血清素能系统的变化,表现为纹状体和脑干中血清素浓度降低,这在5-羟色胺受体激活后影响了对低氧的呼吸反应幅度。